Advertisement

Topics

Companies Related to "Vaccines Market Type vaccines humans vaccines animals Therapeutic" [Most Relevant Company Matches] RSS

03:55 EST 18th February 2019 | BioPortfolio

Here are the most relevant search results for "Vaccines Market Type vaccines humans vaccines animals Therapeutic" found in our extensive corporate database of over 50,000 company records.

Showing "Vaccines Market Type vaccines humans vaccines animals Therapeutic" Companies 1–25 of 6,200+

Extremely Relevant

Novartis Vaccines and Diagnostics

Novartis Vaccines is a global leader in providing vaccines to protect against deadly meningococcal disease. Through industry-leading scientific expertise, the company is focused on extending critical meningococcal vaccines research. In addition to developing Menveo vaccine, Novartis Vaccines is developing a recombinant vaccine for its potential to provide broad coverage against multiple strains of...


Longhorn Vaccines & Diagnostics

Longhorn Vaccines & Diagnostics is a private a biotech company located in San Antonio, TX that develops, and commercializes platform neutral RRT-PCR assays and develops vaccines for infectious diseases.

ASCIInc

ASCIInc is a premiere Healthcare and Life Science Company that understands the labyrinth of possibilities involving immunization and vaccination programs utilizes an intelligent eidetic system including over 320 vaccines and pharmaceuticals currently deployed or in development available to be used to treat 23 classes of Category A, B, or C terrorism agents, from Anthrax to SARS: over 147 prophylac...


Transgene Inc

Mission StatementTransgene is a biopharmaceutical company dedicated to the discovery and development of gene-based therapeutic vaccines and immunotherapy products for the treatment of cancer and infectious diseases.Business StrategyTransgene's business strategy is to develop therapeutic vaccines against cancer and infectious diseases based on its broad technology platform for gene delivery. Transg...

DCPrime

DCPrime develops off-the-shelf dendritic cell-based vaccines for a broad range of cancer types, based on its unique, proprietary technology platform, DCOne™. DCOne-based dendritic cell vaccines, in some indications loaded with cancer antigens for targeted treatment, are used as standardized, therapeutic products. The platform combines the power of den...

GenPhar, Inc

GenPhar, Inc. is a biopharmaceutical company dedicated to becoming a leader in developing and producing prophylactic and therapeutic vaccines to protect against the world's most dangerous diseases. GenPhar’s scientists have developed a complex and adaptive, proprietary vaccine technology designed to develop multivalent vaccines (protects against multiple virus strains) .Successful, safe vaccinat...

Inovio Biomedical Corporation

Inovio Biomedical is focused on the design, development, and delivery of a new generation of vaccines, called DNA vaccines, to prevent and treat cancers and infectious diseases. The company’s SynCon™ technology enables the design of “universal” vaccines capable of protecting against multiple – including newly emergent, unknown – stra...

Inviragen, Inc. and Duke-NUS

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's lead product candidate is a vaccine to protect against dengue fever. Inviragen is also developing vaccines to protect against hand, foot and mouth disease, chikungunya and Japanese encephalitis which affect millions of individuals in Asia. Vaccines in ...

Inviragen, Inc. and PharmaJet, Inc.

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's lead product candidate is a vaccine to protect against dengue fever. Inviragen is also developing vaccines to protect against hand, foot and mouth disease and Japanese encephalitis, both of which affect millions of children in Asia. Vaccines in preclin...

Fina Biosolutions

Fina Biosolutions is a privately-owned R&D biotechnology company located in Rockville, MD. The company provides laboratory services and technology in the field of conjugate vaccines. Chemistry developed by Fina Biosolutions scientists is used in GlaxoSmithKline’s pneumococcal conjugate vaccine, Pfizer’s meningococcal conjugate vaccine and others. ...

Inovio Pharmaceuticals, Inc.

Inovio is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases. The company’s SynCon™ vaccines are designed to provide broad cross-strain protection against known as well as newly emergent strains of pathogens such as influenza. When delivered with Inovio’s proprietary electroporation ...

Iomai

Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, en...

Indian Immunologicals Limited

Indian Immunologicals Ltd (IIL) is a wholly owned subsidiary of National Dairy Development Board, established in 1983. IIL's plant at Hyderabad is built in collaboration with Wellcome Foundation of U.K. In addition to Foot and Mouth Disease (FMD) vaccine under the flagship brand name "Raksha", IIL also produces a range of other veterinary vaccines such as anti-rabies vaccine, Thileriosis vaccine, ...

Cancer Vaccines Ltd

Cancer Vaccines Ltd is a biopharmaceutical company focused on the development and commercialisation of safe and effective therapeutic vaccines for the treatment of cancer. The company was founded in 1999 and won a DTI SMART Award.The attraction of a vaccination based approach to treating cancer is widely acknowledged, and many researchers and clinicians have worked in this area. Historically the a...

VBI Vaccines

VBI Vaccines is a biotechnology company dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. VBI’s innovative approach to vaccine development and growing pipeline of vaccine programs address significant market opportunity an...

Sinovac Biotech Ltd.

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccine products include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), and Anflu(R) (influenza). PanfluTM, Sinovac's pandemic influenza vaccine (H5N1), has already b...

Avant Immunotherapeutics

AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. The company is developing a broad portfolio of vaccines against viral and bacterial diseases, including single-dose oral vaccines aimed a protecting travelers from cholera, typhoid fever and other illnesses. In addition, the co...

AKASAKA INTERNATIONAL CLINIC

It is a new and innovative cancer vaccine consisting of formalin-fixed or paraffin-embedded tissue fragments derived from patient's own cancer (tumor) and immunoadjuvants. It is one of the self-vaccines (auto-vaccines) without any problematic adverse side effects.

MabVax Therapeutics Inc.

MabVax was formed to commercialize the work of Dr. Phil Livingston and colleagues at Memorial Sloan-Kettering Cancer Center (MSKCC) who over the last 25 years have developed monovalent cancer vaccines against ten distinct antigenic targets on various types of cancer cells. These vaccines target gangliosides and other carbohydrate antigens that are the most extensively expressed antigenic targe...

Madison Vaccines Incorporated

Wisconsin-based MVI is developing two plasmid DNA vaccines to treat men with prostate cancer. MVI has licensed patented technologies that were developed in the laboratory of Dr. Douglas McNeel at the University of Wisconsin-Madison. More information is available at www.madisonvaccines.com.

Profectus BioSciences Inc.

Enabled by an experienced development team and two propriety platform technologies in-licensed from Wyeth Vaccines (now Pfizer, Inc.), Profectus BioSciences Inc. is developing the next generation of vaccines for high value unmet targets in biodefense, infectious and emerging diseases.

Juvaris BioTherapeutics, Inc

Juvaris BioTherapeutics is a clinical stage company developing adjuvanted vaccines to treat infectious diseases. The Company’s lead adjuvant, JVRS-100, is a cationic lipid-DNA complex that is being developed as an adjuvant to improve the effectiveness of existing vaccines and to develop new vaccines against a variety of infectious diseases. Research ...

Oxxon Pharmaccines Limited

Oxxon Pharmaccines™ Ltd is a biotechnology company developing novel pharmaccines (therapeutic vaccines) based on its unique PrimeBoost technologies for the treatment of chronic infectious diseases and cancer. We currently have products in clinical trials for the treatment of melanoma and hepatitis B virus, and our founding collaborators have ongoing clinical programmes developing preventative va...

Orchestra Therapeutics

Orchestra Therapeutics’ unique approach to controlling autoimmune diseases uses small peptide vaccines that appear to stimulate FOXP3+ Regulatory T-cells; a component of the immune system that is now recognized as being key in autoimmune pathogenesis. Rather than disrupting the function of the entire immune system, these therapeutic vaccines are designed to elicit a very specific response – ak...

Novavax, Inc.

Novavax, Inc. is a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The company produces potent VLP-based recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create co...


More From BioPortfolio on "Vaccines Market Type vaccines humans vaccines animals Therapeutic"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks